Seizure Disorder

28 registered clinical trials studyying Seizure Disorder — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patien NCT06388707	NaviFUS Corporation	Phase 1 / Phase 2
Withdrawn	Thalamic Stimulation for Epilepsy Study NCT04102254	Duke University	N/A
Completed	NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy NCT04999046	NaviFUS Corporation	N/A
Terminated	Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy NCT04650204	Mayo Clinic	Phase 4
Completed	Detecting Absence Seizures Using Eye Tracking NCT04439656	Rachel Kuperman	—
Active Not Recruiting	Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma NCT04553757	M.D. Anderson Cancer Center	—
Withdrawn	COVID-19 Prevalence and Cognitive Deficits in Neurological Patients NCT04377425	Aarhus University Hospital	—
Unknown	Study to Validate Novel Seizure-Detection Algorithm NCT04291716	Overwatch Digital Health	N/A
Recruiting	Epilepsy Learning Healthcare System (ELHS) NCT06265103	Epilepsy Foundation of America	—
Terminated	Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet NCT03790436	University of Southern California	N/A
Completed	Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy NCT03484039	University of Florida	N/A
Completed	Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients NCT03480555	King Abdullah International Medical Research Center	N/A
Completed	Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiw NCT06542952	National Taiwan University Hospital	—
Completed	Dexmedetomidine and Propofol for Pediatric MRI Sedation NCT03513757	Medical College of Wisconsin	Phase 4
Unknown	Neuroimaging Biomarker for Seizures NCT03441867	Providence VA Medical Center	N/A
Recruiting	Modulating Movement Intention Via Cortical Stimulation NCT03233399	NYU Langone Health	N/A
Unknown	A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy NCT03934268	Children's Hospital of Fudan University	—
Recruiting	Etiology and Treatment of Neonatal Seizure NCT03822741	Children's Hospital of Fudan University	—
Completed	A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome NCT02682927	Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.	Phase 3
Unknown	Policy on Optimal Epilepsy Management NCT01762215	Northern California Institute of Research and Education	N/A
Unknown	External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy NCT01978470	NeuroSigma, Inc.	N/A
Terminated	IVIG Treatment for Refractory Immune-Related Adult Epilepsy NCT01545518	Emory University	Phase 2
Unknown	Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy NCT01450423	Lars Bo Andersen	Phase 2
Completed	Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT NCT01941706	Emory University	N/A
Completed	A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. NCT00433667	SK Life Science, Inc.	Phase 3
Completed	A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. NCT00425282	SK Life Science, Inc.	Phase 3
Completed	Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or P NCT00179517	Beth Israel Deaconess Medical Center	Phase 2
Completed	Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy NCT00179426	Beth Israel Deaconess Medical Center	—